Published in Diabetes Care on March 01, 2009
Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients | NCT03390322
Effect of DMR in the Treatment of NASH (DMR_NASH_001) | NCT03536650
All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev (2012) 1.74
Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg (2009) 1.56
Bariatric surgery and diabetes: who should be offered the option of remission? JAMA (2009) 1.48
Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients. Diabetes (2013) 1.37
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes. Diabetes Care (2013) 1.29
Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg (2013) 1.15
Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity (Silver Spring) (2011) 1.14
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes (2013) 1.09
Type 2 diabetes: etiology and reversibility. Diabetes Care (2013) 1.06
First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc (2011) 1.06
Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab (2010) 1.00
Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? Int J Clin Pract (2009) 0.90
Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. Surg Obes Relat Dis (2013) 0.85
Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion. Diabetes (2015) 0.84
EXTERNAL VALIDATION OF THE DIAREM SCORE AS REMISSION PREDICTOR OF DIABETES MELLITUS TYPE 2 IN OBESE PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS. Arq Bras Cir Dig (2015) 0.84
A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass. World J Surg (2015) 0.83
Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes. Theor Biol Med Model (2013) 0.83
Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: A prospective 2-year follow up. J Diabetes Investig (2013) 0.80
Roux-en-Y gastric bypass in the treatment of non-classic congenital adrenal hyperplasia due to 11-hydroxylase deficiency. BMJ Case Rep (2013) 0.79
The effects of an amino acid supplement on glucose homeostasis, inflammatory markers, and incretins after laparoscopic gastric bypass. J Am Coll Surg (2011) 0.78
Bariatric surgery and T2DM improvement mechanisms: a mathematical model. Theor Biol Med Model (2012) 0.78
Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol (2014) 0.78
Laparoscopic Roux-en-Y gastric bypass with ileal transposition - an alternative surgical treatment for type 2 diabetes mellitus and gastroesophageal reflux. Wideochir Inne Tech Maloinwazyjne (2015) 0.78
Latent autoimmune diabetes in adults presenting as diabetes "recurrence" after bariatric surgery: a case report. Diabetes Care (2013) 0.77
A Systematic Review and Meta-Analysis of Outcomes for Type 1 Diabetes after Bariatric Surgery. J Obes (2016) 0.75
Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial. BMJ Open (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol (1979) 27.52
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
The physiology of glucagon-like peptide 1. Physiol Rev (2007) 9.07
Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med (2005) 6.88
Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med (2004) 6.12
Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes (2002) 5.21
Gastrointestinal regulation of food intake. J Clin Invest (2007) 4.47
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med (2005) 4.04
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg (2006) 3.97
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest (1997) 3.66
The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg (2004) 2.95
Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes (2002) 2.90
Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism (2000) 2.69
Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest (1970) 2.68
Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care (2002) 2.51
Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery (2007) 2.35
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab (2004) 2.21
Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1993) 2.10
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab (1989) 2.07
Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes (2002) 2.06
The adipocyte as an active participant in energy balance and metabolism. Gastroenterology (2007) 2.02
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes (2007) 1.96
National trends in bariatric surgery, 1996-2002. Arch Surg (2006) 1.92
Bariatric surgery for severely obese adolescents. J Gastrointest Surg (2003) 1.92
Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes (2006) 1.89
Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care (2005) 1.88
Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia (2007) 1.84
Retracted Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest (1978) 1.73
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) (2005) 1.72
Update on obesity. J Clin Endocrinol Metab (2008) 1.65
GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg (2006) 1.60
Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes (2008) 1.59
Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1985) 1.51
Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes (2003) 1.49
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol (2003) 1.44
Popular weight-loss diets: from evidence to practice. Nat Clin Pract Cardiovasc Med (2007) 1.42
Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab (2002) 1.41
Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc (2008) 1.35
Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia (2007) 1.31
Effect of weight reduction on in vitro adipose tissue lipolysis and cellularity in obese adolescents and adults. Diabetes (1972) 1.19
An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg (2008) 1.17
beta-cell function in obesity: effects of weight loss. Diabetes (2004) 1.13
Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med (1984) 1.10
Does diabetes affect weight loss after gastric bypass? Surg Obes Relat Dis (2007) 1.10
Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med (2005) 1.08
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia (2006) 1.06
Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg (2008) 1.06
Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res (2007) 1.05
Insulin binding and hexose transport in rat adipocytes. Relation to cell size. Diabetologia (1980) 1.05
Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med (2003) 1.05
In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery. Obes Surg (2008) 1.04
Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg (2007) 1.02
Effect of weight loss on whole body and cellular lipid metabolism in severely obese humans. Am J Physiol (1996) 1.01
Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. Eur J Endocrinol (2008) 0.99
Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg (2006) 0.98
Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab (2004) 0.98
Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance. J Lipid Res (2006) 0.96
Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity (Silver Spring) (2008) 0.95
Internal biliary diversion improves glucose tolerance in the rat. Am J Physiol (1985) 0.93
Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab (2000) 0.93
Insulin resistance of stress: sites and mechanisms. Clin Sci (Lond) (1993) 0.91
Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab (1998) 0.90
Surgical treatment of morbid obesity. Annu Rev Med (2006) 0.90
Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg (2006) 0.90
Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care (2007) 0.89
Insulin and the burned patient. Crit Care Med (2007) 0.89
Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about? Diabetes Care (2008) 0.89
Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? Diab Vasc Dis Res (2007) 0.88
Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome. Clin Infect Dis (2003) 0.88
Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women? Clin Endocrinol (Oxf) (2005) 0.87
The insulin tolerance test in morbidly obese patients undergoing bariatric surgery. Obes Res (2001) 0.85
White blood cells in obesity and diabetes: effects of weight loss and normalization of glucose metabolism. Diabetes Care (2004) 0.84
Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass. Obes Surg (2006) 0.81
Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr (2005) 0.81
Long-term follow-up and the role of surgery in adolescents with morbid obesity. Surg Obes Relat Dis (2005) 0.80
A possible role of GLP-1 in the pathophysiology of early dumping syndrome. Dig Dis Sci (2005) 0.79
Relationship between sympathetic reactivity and body weight loss in morbidly obese subjects. Int J Obes Relat Metab Disord (2004) 0.78
Should eligibility for bariatric surgery be expanded? Gastroenterology (2008) 0.76
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg (2006) 3.97
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int (2011) 2.14
Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes (2006) 1.89
Increased serum high-density lipoprotein-cholesterol concentration in celiac disease after gluten-free diet treatment correlates with body fat stores. J Clin Gastroenterol (2009) 1.54
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. Diabetes Care (2007) 1.48
Micro- and macroscopic structural modification of subcutaneous adipose tissue after bariatric surgery. Aesthetic Plast Surg (2012) 1.39
Insulin clearance in obesity. J Am Coll Nutr (2003) 1.38
Postprandial hypertriglyceridemia predicts improvement in insulin resistance in obese patients after bariatric surgery. Surg Obes Relat Dis (2011) 1.37
First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care (2008) 1.28
Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab (2004) 1.21
Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab (2006) 1.16
Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny. J Lipid Res (2008) 1.14
beta-cell function in obesity: effects of weight loss. Diabetes (2004) 1.13
Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care (2011) 1.13
Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg (2015) 1.09
Dermal histomorphology in postbariatric patients: bilopancreatic diversion versus gastric bypass. Ann Plast Surg (2013) 1.08
One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care (2010) 1.04
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia (2013) 1.00
Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim Biophys Acta (2010) 1.00
Insulin granule trafficking in beta-cells: mathematical model of glucose-induced insulin secretion. Am J Physiol Endocrinol Metab (2007) 0.95
Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg (2013) 0.93
Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes Res (2004) 0.91
Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients. Obes Res (2003) 0.91
Nonalcoholic fatty liver disease in children. J Am Coll Nutr (2008) 0.91
Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care (2007) 0.89
Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects. Am J Physiol Endocrinol Metab (2006) 0.88
Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes (2004) 0.88
Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test. Am J Physiol Endocrinol Metab (2011) 0.88
Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance. PLoS One (2013) 0.88
Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity (Silver Spring) (2008) 0.88
Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile. Diabetes Care (2009) 0.88
Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care (2010) 0.87
Wound healing process in post-bariatric patients: an experimental evaluation. Obes Surg (2010) 0.86
Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Diabetes Care (2007) 0.86
Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res (2005) 0.86
Effects of weight loss and calorie restriction on carbohydrate metabolism. Curr Opin Clin Nutr Metab Care (2005) 0.84
Bioimpedance analysis: a useful technique for assessing appendicular lean soft tissue mass and distribution. J Appl Physiol (1985) (2003) 0.84
The ingestion of saturated fatty acid triacylglycerols acutely affects insulin secretion and insulin sensitivity in human subjects. Br J Nutr (2004) 0.84
The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity. Obes Surg (2010) 0.83
Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test. Theor Biol Med Model (2010) 0.83
Duodenal-jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes (2013) 0.83
Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery. Obesity (Silver Spring) (2007) 0.82
Approximate linear confidence and curvature of a kinetic model of dodecanedioic acid in humans. Am J Physiol Endocrinol Metab (2005) 0.82
A mathematical model of the euglycemic hyperinsulinemic clamp. Theor Biol Med Model (2005) 0.82
Thromboxane production in morbidly obese subjects. Am J Cardiol (2011) 0.81
Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr (2005) 0.81
Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand J Gastroenterol (2005) 0.81
Effect of oral sebacic Acid on postprandial glycemia, insulinemia, and glucose rate of appearance in type 2 diabetes. Diabetes Care (2010) 0.80
NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test. Am J Physiol Endocrinol Metab (2007) 0.80
Morbidly obese patients undergoing bariatric and body contouring surgery: psychological evaluation after treatments. J Plast Reconstr Aesthet Surg (2011) 0.80
Menopause, insulin resistance, and risk factors for cardiovascular disease. Menopause (2006) 0.80
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. Diabetes (2011) 0.79
"Kris knife" brachioplasty after bariatric surgery and massive weight loss. Aesthetic Plast Surg (2013) 0.79
Endothelial progenitor cells in morbid obesity. Circ J (2014) 0.79
Hypocalcemia complicating near-total thyroidectomy in patients with coexisting lipid malabsorption due to biliopancreatic diversion. Obes Surg (2004) 0.79
The effect of gastrointestinal surgery on insulin resistance and insulin secretion. Curr Atheroscler Rep (2012) 0.79
Twenty-four hour energy expenditure and skeletal muscle gene expression changes after bariatric surgery. J Clin Endocrinol Metab (2013) 0.79
Effect of gastric bypass versus diet on cardiovascular risk factors. Ann Surg (2014) 0.79
Underestimation of urinary albumin to creatinine ratio in morbidly obese subjects due to high urinary creatinine excretion. Clin Nutr (2011) 0.79
Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects. Obes Res (2003) 0.78
Ghrelin does not influence gastric emptying in obese subjects. Obes Res (2005) 0.78
Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects. Am J Physiol Endocrinol Metab (2013) 0.78
Absence of allergic reactions to egg white lysozyme additive in Grana Padano cheese. J Am Coll Nutr (2008) 0.77
The MRC1/CD68 ratio is positively associated with adipose tissue lipogenesis and with muscle mitochondrial gene expression in humans. PLoS One (2013) 0.77
Biliopancreatic diversion as a novel approach to the HAIR-AN syndrome. Obes Surg (2005) 0.77
Reduced expression of uncoupling proteins-2 and -3 in adipose tissue in post-obese patients submitted to biliopancreatic diversion. Eur J Endocrinol (2003) 0.77
Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. Obes Surg (2010) 0.76
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects. Eur J Intern Med (2011) 0.76
Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion. Obes Surg (2009) 0.75
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications. Int J Cardiol (2013) 0.75
Clearance approach in hyperinsulinemic-euglycemic clamp evaluation in lean and obese subjects. Endocr Res (2014) 0.75
Leukocyte Activation in Obese Patients: Effect of Bariatric Surgery. Medicine (Baltimore) (2015) 0.75
How to consider low serum vitamin D as a risk factor for insulin resistance? Am J Clin Nutr (2004) 0.75
Effects of transoral gastroplasty on glucose homeostasis in obese subjects. J Clin Endocrinol Metab (2013) 0.75
Postabdominoplasty Wound Dehiscence in Bariatric Patients: Biliopancreatic Diversion Versus Gastric Bypass: A Preliminary Study. Ann Plast Surg (2015) 0.75
Changes in fat mass influence SREBP-1c and UCP-2 gene expression in formerly obese subjects. Obes Res (2005) 0.75
Lowering of circulating free-fatty acids levels and reduced expression of leptin in white adipose tissue in postobesity status. J Investig Med (2002) 0.75
Immunological response in egg-sensitive adults challenged with cheese containing or not containing lysozyme. J Am Coll Nutr (2012) 0.75
A case of atypical retrosternal chest pain. Am J Med (2012) 0.75
Effects of binge eating behavior on fuel oxidation and body composition. J Am Coll Nutr (2005) 0.75